Radiographic staging of mediastinal lymph nodes in non-small cell lung cancer patients.
In conclusion, accurate pretreatment staging of NSCLC patients is essential so that they undergo the most appropriate treatment. Imaging studies play an integral part in clinical staging. The preferred imaging method for staging the mediastinum is PET/CT, preferably integrated. Until the sensitivity and accuracy of imaging studies are equivalent to the available MLN biopsy techniques, all candidates for definitive therapy require histologic assessment of the mediastinum.
Groth
Shawn S
SS
University of Minnesota Department of Surgery, Division of General Thoracic and Foregut Surgery, MMC 207, 420 Delaware Street, SE, Minneapolis, MN 55455, USA. groth015@umn.edu
Whitson
Bryan A
BA
Maddaus
Michael A
MA
D002289:Carcinoma, Non-Small-Cell Lung / Q000556:secondary*; D006801:Humans; D008175:Lung Neoplasms / Q000473:pathology*; D008198:Lymph Nodes / Q000000981:diagnostic imaging / Q000473:pathology*; D008207:Lymphatic Metastasis; D008279:Magnetic Resonance Imaging; D008482:Mediastinum; D009367:Neoplasm Staging; D049268:Positron-Emission Tomography; D014057:Tomography, X-Ray Computed / Q000379:methods*